1life Healthcare Stock Price To Sales
| ONEMDelisted Stock | USD 16.47 0.00 0.00% |
1Life Healthcare fundamentals help investors to digest information that contributes to 1Life Healthcare's financial success or failures. It also enables traders to predict the movement of 1Life Stock. The fundamental analysis module provides a way to measure 1Life Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 1Life Healthcare stock.
1Life |
1Life Healthcare Company Price To Sales Analysis
1Life Healthcare's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current 1Life Healthcare Price To Sales | 3.46 X |
Most of 1Life Healthcare's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 1Life Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
CompetitionBased on the latest financial disclosure, 1Life Healthcare has a Price To Sales of 3.4585 times. This is 83.84% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The price to sales for all United States stocks is 69.72% higher than that of the company.
1Life Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 1Life Healthcare's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 1Life Healthcare could also be used in its relative valuation, which is a method of valuing 1Life Healthcare by comparing valuation metrics of similar companies.1Life Healthcare is currently under evaluation in price to sales category among its peers.
1Life Fundamentals
| Return On Equity | -0.23 | |||
| Return On Asset | -0.0882 | |||
| Profit Margin | (0.39) % | |||
| Operating Margin | (0.37) % | |||
| Current Valuation | 3.85 B | |||
| Shares Outstanding | 204.35 M | |||
| Shares Owned By Insiders | 1.97 % | |||
| Shares Owned By Institutions | 87.10 % | |||
| Number Of Shares Shorted | 15.16 M | |||
| Price To Book | 2.23 X | |||
| Price To Sales | 3.46 X | |||
| Revenue | 621.55 M | |||
| Gross Profit | 188.13 M | |||
| EBITDA | (196.19 M) | |||
| Net Income | (254.64 M) | |||
| Cash And Equivalents | 347.62 M | |||
| Cash Per Share | 1.78 X | |||
| Total Debt | 309.84 M | |||
| Debt To Equity | 0.39 % | |||
| Current Ratio | 2.59 X | |||
| Book Value Per Share | 7.93 X | |||
| Cash Flow From Operations | (88.57 M) | |||
| Short Ratio | 6.23 X | |||
| Earnings Per Share | (1.81) X | |||
| Price To Earnings To Growth | 0.20 X | |||
| Target Price | 18.18 | |||
| Number Of Employees | 3.09 K | |||
| Beta | 1.99 | |||
| Market Capitalization | 3.37 B | |||
| Total Asset | 2.63 B | |||
| Retained Earnings | (303.26 M) | |||
| Working Capital | 126.83 M | |||
| Current Asset | 205.89 M | |||
| Current Liabilities | 79.06 M | |||
| Z Score | 6.0 | |||
| Net Asset | 2.63 B |
About 1Life Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 1Life Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 1Life Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 1Life Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in 1Life Stock
If you are still planning to invest in 1Life Healthcare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the 1Life Healthcare's history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |